Vascular malformation
Therapeutic area
Vascular Medicine
Rare disease
No
- Definition
- A non-neoplastic disorder that is the result of defects of vascular morphogenesis.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Vascular malformation
- Therapeutic area
- Vascular Medicine
- vascular malformation
- vascular malformation
- malformation, vascular
- malformations, vascular
- Severity
- Unknown
- Cardiology
- Vascular Medicine
- MONDO ID
- MONDO:0024291
- Parent condition
- MONDO:0005385
Related records
Broader conditions (5)
- Cardiovascular disorder
- Disease
- Disease by body system or component
- Human disease
- Vascular disorder
Narrower conditions (9)
- Capillary malformation-arteriovenous malformation 2
- Cerebral proliferative angiopathy
- Congenital vascular malformation
- EPHB4-associated vascular malformation spectrum
- Fibro-adipose vascular anomaly
- Glomuvenous malformation
- Lymphatic malformation 7
- Parkes Weber syndrome
- Splenic venous malformation
Trials (77)
- 24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs
- 24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs
- A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease
- A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology
- A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
- A Study of Clinical Practice and Real-world Care of Patients Treated With mTOR, PI3K, and MEK Inhibitors for Extracranial Vascular Anomalies
- A Study of Enalapril in Treatment of Venous Malformations
- A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
- A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
- A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies
- A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
- An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations
- Aneurysm Genetic Risk in Patients With QIB Changes
- AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)
- Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study
- Bioseal Dural Sealing Study BIOS-14-001
- Bleomycin Electrosclerotherapy (BEST) for Slow-flow Vascular Malformations
- Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study
- Bone Health in Patients With Overgrowth
- Can we Use Resting-state fMRI and CSD Fiber Tractography for Presurgical Mapping?
Drugs in development (3)
- Everolimus Phase 2
- Sirolimus Phase 2
- Thalidomide Phase 3
Other linked drugs (1)
- Bleomycin